Taconic's RNAi Technology

New RNAi Publications Gamma-secretase activating protein is a therapeutic target for Alzheimer's diseaseCardiac and skeletal muscle defects in a mouse model of human Barth syndrome

Why choose Taconic's RNAi Technology?

Learn more about Taconic's RNAi technology



New Products:


Two in one - Knock down two genes at the same time!

Inducible miRNA Overexpression

Inducible RNAi in Rats



How Taconic's inducible in vivo RNAi gene knockdown works:

How Taconic's inducible <I>in vivo</I> RNAi gene knockdown works

Taconic's innovative RNAi models enable you to reversibly induce RNA mediated gene knockdown, in vivo, at selected time points. In the absence of inducer (doxycycline), the tet-repressor protein binds to the tet-operator control element and effectively inhibits shRNA expression from the H1 promoter. When doxycycline is administered through an animal's feed or drinking water, it binds to the tet-repressor protein and blocks its interaction with the H1 promoter. This is followed by H1 promoter activation, shRNA expression and effective RNA mediated gene-knockdown. Withdrawal of doxycycline inhibits shRNA expression resulting in pre-knockdown levels of target gene expression.

Top of the page